And yet the essential matter is not complicated. It can be explained in a sentence: Six hundred dollars is the price we want insurers to pay.
Insurers are not spending your money. They are spending everybody’s money. Look at it from the perspective of health-care providers, drugmakers or medical-device suppliers. All of us are competing for a common pot of loot. Naturally, each wants to maximize his share. That’s human nature.
. . . .
Now you know why we offer coupons and rebates to individual consumers. This is our way of trying to re-desensitize customers to the price of EpiPen in order to counter the efforts of insurers to re-sensitize them by hitting them with copays and deductibles.